|
|
lymphocyte differentiation
|
GO:0030098 |
242 |
0.646
|
|
|
|
leukocyte differentiation
|
GO:0002521 |
342 |
0.498
|
|
|
|
immune effector process
|
GO:0002252 |
321 |
0.475
|
|
|
|
immune response regulating cell surface receptor signaling pathway
|
GO:0002768 |
80 |
0.467
|
|
|
|
regulation of adaptive immune response
|
GO:0002819 |
90 |
0.457
|
|
|
|
t cell differentiation
|
GO:0030217 |
174 |
0.429
|
|
|
|
immune response activating cell surface receptor signaling pathway
|
GO:0002429 |
72 |
0.410
|
|
|
|
single organismal cell cell adhesion
|
GO:0016337 |
131 |
0.406
|
|
|
|
cytokine production
|
GO:0001816 |
319 |
0.405
|
|
|
|
antigen receptor mediated signaling pathway
|
GO:0050851 |
64 |
0.394
|
|
|
|
regulation of lymphocyte anergy
|
GO:0002911 |
4 |
0.367
|
|
|
|
multicellular organismal signaling
|
GO:0035637 |
91 |
0.366
|
|
|
|
regulation of cell activation
|
GO:0050865 |
289 |
0.363
|
|
|
|
adaptive immune response
|
GO:0002250 |
155 |
0.343
|
|
|
|
alpha beta t cell activation
|
GO:0046631 |
91 |
0.341
|
|
|
|
positive regulation of cellular amine metabolic process
|
GO:0033240 |
5 |
0.330
|
|
|
|
single organism cell adhesion
|
GO:0098602 |
156 |
0.305
|
|
|
|
t cell activation
|
GO:0042110 |
289 |
0.293
|
|
|
|
peptidyl amino acid modification
|
GO:0018193 |
336 |
0.288
|
|
|
|
adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains
|
GO:0002460 |
145 |
0.287
|
|
|
|
positive regulation of lymphocyte activation
|
GO:0051251 |
140 |
0.279
|
|
|
|
positive regulation of t cell proliferation
|
GO:0042102 |
52 |
0.275
|
|
|
|
positive regulation of lymphocyte mediated immunity
|
GO:0002708 |
62 |
0.274
|
|
|
|
positive regulation of cellular amino acid metabolic process
|
GO:0045764 |
3 |
0.272
|
|
|
|
regulation of cellular amine metabolic process
|
GO:0033238 |
20 |
0.268
|
|
|
|
regulation of t cell activation
|
GO:0050863 |
170 |
0.268
|
|
|
|
neuronal action potential
|
GO:0019228 |
54 |
0.265
|
|
|
|
telencephalon development
|
GO:0021537 |
186 |
0.257
|
|
|
|
immune response regulating signaling pathway
|
GO:0002764 |
125 |
0.246
|
|
|
|
positive regulation of t cell activation
|
GO:0050870 |
101 |
0.244
|
|
|
|
regulation of lymphocyte activation
|
GO:0051249 |
240 |
0.244
|
|
|
|
regulation of calcium mediated signaling
|
GO:0050848 |
19 |
0.243
|
|
|
|
regulation of t cell anergy
|
GO:0002667 |
4 |
0.226
|
|
|
|
leukocyte proliferation
|
GO:0070661 |
172 |
0.217
|
|
|
|
regulation of cellular ketone metabolic process
|
GO:0010565 |
66 |
0.215
|
|
|
|
regulation of angiogenesis
|
GO:0045765 |
81 |
0.215
|
|
|
|
lymphocyte mediated immunity
|
GO:0002449 |
139 |
0.213
|
|
|
|
organ growth
|
GO:0035265 |
117 |
0.211
|
|
|
|
cellular ketone metabolic process
|
GO:0042180 |
84 |
0.202
|
|
|
|
t cell receptor signaling pathway
|
GO:0050852 |
46 |
0.200
|
|
|
|
cellular amine metabolic process
|
GO:0044106 |
44 |
0.200
|
|
|
|
gliogenesis
|
GO:0042063 |
141 |
0.194
|
|
|
|
protein maturation
|
GO:0051604 |
176 |
0.194
|
|
|
|
amine metabolic process
|
GO:0009308 |
45 |
0.180
|
|
|
|
apoptotic signaling pathway
|
GO:0097190 |
306 |
0.175
|
|
|
|
ensheathment of neurons
|
GO:0007272 |
76 |
0.167
|
|
|
|
activation of immune response
|
GO:0002253 |
138 |
0.167
|
|
|
|
positive regulation of cell activation
|
GO:0050867 |
158 |
0.165
|
|
|
|
regulation of cellular amino acid metabolic process
|
GO:0006521 |
5 |
0.164
|
|
|
|
myeloid cell differentiation
|
GO:0030099 |
233 |
0.160
|
|
|
|
cellular lipid metabolic process
|
GO:0044255 |
323 |
0.156
|
|
|
|
cytokine mediated signaling pathway
|
GO:0019221 |
115 |
0.152
|
|
|
|
leukocyte mediated immunity
|
GO:0002443 |
174 |
0.150
|
|
|
|
cell adhesion
|
GO:0007155 |
329 |
0.147
|
|
|
|
glial cell differentiation
|
GO:0010001 |
131 |
0.146
|
|
|
|
t cell proliferation
|
GO:0042098 |
120 |
0.146
|
|
|
|
action potential
|
GO:0001508 |
78 |
0.145
|
|
|
|
maintenance of location
|
GO:0051235 |
89 |
0.143
|
|
|
|
second messenger mediated signaling
|
GO:0019932 |
73 |
0.143
|
|
|
|
small gtpase mediated signal transduction
|
GO:0007264 |
97 |
0.142
|
|
|
|
positive regulation of lymphocyte anergy
|
GO:0002913 |
4 |
0.141
|
|
|
|
defense response to other organism
|
GO:0098542 |
197 |
0.140
|
|
|
|
interferon gamma production
|
GO:0032609 |
67 |
0.139
|
|
|
|
peptidyl tyrosine modification
|
GO:0018212 |
145 |
0.139
|
|
|
|
mapk cascade
|
GO:0000165 |
281 |
0.134
|
|
|
|
negative regulation of immune system process
|
GO:0002683 |
209 |
0.133
|
|
|
|
lymphocyte anergy
|
GO:0002249 |
4 |
0.131
|
|
|
|
protein processing
|
GO:0016485 |
163 |
0.130
|
|
|
|
cell activation involved in immune response
|
GO:0002263 |
126 |
0.125
|
|
|
|
positive regulation of t cell anergy
|
GO:0002669 |
4 |
0.123
|
|
|
|
myeloid leukocyte differentiation
|
GO:0002573 |
119 |
0.123
|
|
|
|
regulation of leukocyte mediated immunity
|
GO:0002703 |
104 |
0.123
|
|
|
|
metal ion homeostasis
|
GO:0055065 |
189 |
0.122
|
|
|
|
positive regulation of lymphocyte proliferation
|
GO:0050671 |
70 |
0.120
|
|
|
|
thymic t cell selection
|
GO:0045061 |
22 |
0.119
|
|
|
|
positive regulation of mapk cascade
|
GO:0043410 |
170 |
0.119
|
|
|
|
sequestering of calcium ion
|
GO:0051208 |
18 |
0.119
|
|
|
|
regulation of cytokine production
|
GO:0001817 |
266 |
0.119
|
|
|
|
leukocyte activation involved in immune response
|
GO:0002366 |
126 |
0.118
|
|
|
|
t cell costimulation
|
GO:0031295 |
14 |
0.118
|
|
|
|
transmission of nerve impulse
|
GO:0019226 |
76 |
0.117
|
|
|
|
myelination
|
GO:0042552 |
74 |
0.115
|
|
|
|
cellular amino acid metabolic process
|
GO:0006520 |
103 |
0.110
|
|
|
|
endocytosis
|
GO:0006897 |
168 |
0.109
|
|
|
|
regulation of nucleoside metabolic process
|
GO:0009118 |
130 |
0.109
|
|
|
|
negative thymic t cell selection
|
GO:0045060 |
12 |
0.108
|
|
|
|
inflammatory response
|
GO:0006954 |
244 |
0.107
|
|
|
|
interleukin 8 secretion
|
GO:0072606 |
3 |
0.107
|
|
|
|
alpha beta t cell proliferation
|
GO:0046633 |
21 |
0.106
|
|
|
|
negative t cell selection
|
GO:0043383 |
13 |
0.104
|
|
|
|
regulation of cell motility
|
GO:2000145 |
236 |
0.102
|
|
|
|
divalent inorganic cation homeostasis
|
GO:0072507 |
138 |
0.100
|
|
|
|
blood circulation
|
GO:0008015 |
195 |
0.099
|
|
|
|
cytokine secretion
|
GO:0050663 |
72 |
0.096
|
|
|
|
regulation of asymmetric cell division
|
GO:0009786 |
4 |
0.095
|
|
|
|
regulation of leukocyte proliferation
|
GO:0070663 |
121 |
0.093
|
|
|
|
regulation of cytokine secretion
|
GO:0050707 |
61 |
0.092
|
|
|
|
positive regulation of calcium mediated signaling
|
GO:0050850 |
15 |
0.092
|
|
|
|
immune response activating signal transduction
|
GO:0002757 |
116 |
0.092
|
|
|
|
angiogenesis
|
GO:0001525 |
201 |
0.091
|
|
|
|
release of sequestered calcium ion into cytosol
|
GO:0051209 |
42 |
0.091
|
|
|
|
cation transport
|
GO:0006812 |
399 |
0.089
|
|
|
|
positive regulation of t cell costimulation
|
GO:2000525 |
2 |
0.087
|
|
|
|
t cell anergy
|
GO:0002870 |
4 |
0.086
|
|
|
|
regulation of body fluid levels
|
GO:0050878 |
162 |
0.086
|
|
|
|
t cell mediated immunity
|
GO:0002456 |
50 |
0.085
|
|
|
|
regulation of protein serine threonine kinase activity
|
GO:0071900 |
157 |
0.084
|
|
|
|
regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains
|
GO:0002822 |
87 |
0.083
|
|
|
|
divalent metal ion transport
|
GO:0070838 |
172 |
0.082
|
|
|
|
positive regulation of alpha beta t cell activation
|
GO:0046635 |
39 |
0.081
|
|
|
|
g protein coupled receptor signaling pathway
|
GO:0007186 |
243 |
0.081
|
|
|
|
forebrain development
|
GO:0030900 |
302 |
0.080
|
|
|
|
negative regulation of cell development
|
GO:0010721 |
169 |
0.080
|
|
|
|
regulation of interferon gamma production
|
GO:0032649 |
57 |
0.079
|
|
|
|
positive regulation of cell migration
|
GO:0030335 |
109 |
0.078
|
|
|
|
t cell differentiation in thymus
|
GO:0033077 |
77 |
0.078
|
|
|
|
regulation of membrane potential
|
GO:0042391 |
192 |
0.077
|
|
|
|
divalent inorganic cation transport
|
GO:0072511 |
178 |
0.077
|
|
|
|
regulation of secretion by cell
|
GO:1903530 |
249 |
0.076
|
|
|
|
regulation of lymphocyte mediated immunity
|
GO:0002706 |
84 |
0.073
|
|
|
|
morphogenesis of a branching epithelium
|
GO:0061138 |
193 |
0.073
|
|
|
|
regulation of response to wounding
|
GO:1903034 |
189 |
0.072
|
|
|
|
regulation of alpha beta t cell proliferation
|
GO:0046640 |
18 |
0.072
|
|
|
|
calcium ion homeostasis
|
GO:0055074 |
127 |
0.071
|
|
|
|
regulation of alpha beta t cell activation
|
GO:0046634 |
53 |
0.070
|
|
|
|
regulation of interleukin 2 production
|
GO:0032663 |
28 |
0.070
|
|
|
|
neuron migration
|
GO:0001764 |
122 |
0.069
|
|
|
|
innate immune response
|
GO:0045087 |
157 |
0.069
|
|
|
|
response to lipopolysaccharide
|
GO:0032496 |
128 |
0.068
|
|
|
|
ras protein signal transduction
|
GO:0007265 |
77 |
0.068
|
|
|
|
exocytosis
|
GO:0006887 |
121 |
0.067
|
|
|
|
regulation of t cell proliferation
|
GO:0042129 |
92 |
0.067
|
|
|
|
regulation of cell projection organization
|
GO:0031344 |
206 |
0.066
|
|
|
|
helper t cell chemotaxis
|
GO:0035704 |
1 |
0.065
|
|
|
|
extrinsic apoptotic signaling pathway
|
GO:0097191 |
126 |
0.065
|
|
|
|
peptidyl tyrosine phosphorylation
|
GO:0018108 |
143 |
0.065
|
|
|
|
positive regulation of leukocyte mediated immunity
|
GO:0002705 |
70 |
0.065
|
|
|
|
positive regulation of immune effector process
|
GO:0002699 |
107 |
0.064
|
|
|
|
circulatory system process
|
GO:0003013 |
197 |
0.064
|
|
|
|
regulation of peptidyl tyrosine phosphorylation
|
GO:0050730 |
93 |
0.064
|
|
|
|
sequestering of metal ion
|
GO:0051238 |
19 |
0.064
|
|
|
|
response to fibroblast growth factor
|
GO:0071774 |
47 |
0.063
|
|
|
|
regulation of protein transport
|
GO:0051223 |
163 |
0.062
|
|
|
|
negative regulation of synapse assembly
|
GO:0051964 |
3 |
0.062
|
|
|
|
regulation of cell adhesion
|
GO:0030155 |
154 |
0.062
|
|
|
|
nucleoside phosphate metabolic process
|
GO:0006753 |
338 |
0.062
|
|
|
|
calcium mediated signaling
|
GO:0019722 |
46 |
0.061
|
|
|
|
negative regulation of eosinophil degranulation
|
GO:0043310 |
1 |
0.061
|
|
|
|
regulation of interferon gamma mediated signaling pathway
|
GO:0060334 |
3 |
0.060
|
|
|
|
regulation of neuron differentiation
|
GO:0045664 |
281 |
0.060
|
|
|
|
regulation of canonical wnt signaling pathway
|
GO:0060828 |
82 |
0.060
|
|
|
|
regulation of eosinophil degranulation
|
GO:0043309 |
1 |
0.059
|
|
|
|
regulation of monocyte chemotaxis
|
GO:0090025 |
3 |
0.059
|
|
|
|
regulation of epithelial cell proliferation
|
GO:0050678 |
141 |
0.059
|
|
|
|
response to acid chemical
|
GO:0001101 |
111 |
0.058
|
|
|
|
positive regulation of adaptive immune response
|
GO:0002821 |
61 |
0.058
|
|
|
|
regulation of protein kinase activity
|
GO:0045859 |
232 |
0.058
|
|
|
|
regulation of endocytosis
|
GO:0030100 |
69 |
0.057
|
|
|
|
regulation of lymphocyte apoptotic process
|
GO:0070228 |
41 |
0.057
|
|
|
|
interleukin 4 production
|
GO:0032633 |
24 |
0.057
|
|
|
|
cell killing
|
GO:0001906 |
67 |
0.057
|
|
|
|
canonical wnt signaling pathway
|
GO:0060070 |
130 |
0.056
|
|
|
|
phospholipid metabolic process
|
GO:0006644 |
87 |
0.056
|
|
|
|
muscle tissue development
|
GO:0060537 |
308 |
0.056
|
|
|
|
positive regulation of cell death
|
GO:0010942 |
224 |
0.056
|
|
|
|
positive regulation of secretion
|
GO:0051047 |
130 |
0.055
|
|
|
|
natural killer cell inhibitory signaling pathway
|
GO:0002769 |
2 |
0.055
|
|
|
|
negative regulation of immune effector process
|
GO:0002698 |
55 |
0.055
|
|
|
|
negative regulation of protein metabolic process
|
GO:0051248 |
282 |
0.055
|
|
|
|
carbohydrate derivative biosynthetic process
|
GO:1901137 |
183 |
0.054
|
|
|
|
smoothened signaling pathway
|
GO:0007224 |
105 |
0.054
|
|
|
|
t cell selection
|
GO:0045058 |
34 |
0.054
|
|
|
|
sensory perception
|
GO:0007600 |
245 |
0.054
|
|
|
|
regulation of interleukin 8 secretion
|
GO:2000482 |
2 |
0.053
|
|
|
|
blastocyst growth
|
GO:0001832 |
23 |
0.053
|
|
|
|
axon ensheathment
|
GO:0008366 |
76 |
0.053
|
|
|
|
aromatic compound catabolic process
|
GO:0019439 |
286 |
0.052
|
|
|
|
endocrine system development
|
GO:0035270 |
98 |
0.052
|
|
|
|
inner cell mass cell proliferation
|
GO:0001833 |
15 |
0.052
|
|
|
|
oligodendrocyte differentiation
|
GO:0048709 |
53 |
0.052
|
|
|
|
platelet activation
|
GO:0030168 |
40 |
0.051
|
|
|
|
muscle cell development
|
GO:0055001 |
133 |
0.051
|
|
|
|
regulation of lymphocyte proliferation
|
GO:0050670 |
117 |
0.051
|
|
|
|
muscle contraction
|
GO:0006936 |
101 |
0.051
|
|
|
|
germ cell development
|
GO:0007281 |
185 |
0.051
|
|
|
|
b cell activation
|
GO:0042113 |
161 |
0.051
|
|
|
|
cellular response to fibroblast growth factor stimulus
|
GO:0044344 |
47 |
0.051
|
|
|
|
positive regulation of monocyte chemotaxis
|
GO:0090026 |
2 |
0.051
|
|
|
|
regulation of neuron projection development
|
GO:0010975 |
169 |
0.051
|
|
|
|
cd8 positive alpha beta t cell extravasation
|
GO:0035697 |
3 |
0.050
|
|
|
|
positive regulation of cell development
|
GO:0010720 |
237 |
0.050
|
|
|
|
positive regulation of nervous system development
|
GO:0051962 |
221 |
0.050
|
|
|
|
lymphocyte proliferation
|
GO:0046651 |
164 |
0.050
|
|
|
|
cerebral cortex cell migration
|
GO:0021795 |
44 |
0.049
|
|
|
|
positive regulation of interleukin 8 secretion
|
GO:2000484 |
1 |
0.049
|
|
|
|
organic hydroxy compound metabolic process
|
GO:1901615 |
203 |
0.049
|
|
|
|
cardiac chamber development
|
GO:0003205 |
108 |
0.049
|
|
|
|
wnt signaling pathway
|
GO:0016055 |
188 |
0.048
|
|
|
|
regulation of map kinase activity
|
GO:0043405 |
120 |
0.048
|
|
|
|
hematopoietic stem cell migration
|
GO:0035701 |
1 |
0.047
|
|
|
|
nucleobase containing small molecule metabolic process
|
GO:0055086 |
352 |
0.047
|
|
|
|
positive regulation of epithelial cell proliferation
|
GO:0050679 |
68 |
0.047
|
|
|
|
regulation of hydrolase activity
|
GO:0051336 |
246 |
0.047
|
|
|
|
regulation of lipid metabolic process
|
GO:0019216 |
118 |
0.047
|
|
|
|
cell fate specification
|
GO:0001708 |
72 |
0.046
|
|
|
|
regulation of blood pressure
|
GO:0008217 |
93 |
0.046
|
|
|
|
lymphocyte apoptotic process
|
GO:0070227 |
54 |
0.046
|
|
|
|
positive regulation of cell adhesion
|
GO:0045785 |
80 |
0.046
|
|
|
|
cardiac muscle tissue development
|
GO:0048738 |
130 |
0.046
|
|
|
|
epithelial cell proliferation
|
GO:0050673 |
174 |
0.046
|
|
|
|
regulation of cd8 positive alpha beta t cell extravasation
|
GO:2000449 |
3 |
0.046
|
|
|
|
pharynx development
|
GO:0060465 |
1 |
0.046
|
|
|
|
regulation of cellular component biogenesis
|
GO:0044087 |
181 |
0.045
|
|
|
|
cytosolic calcium ion homeostasis
|
GO:0051480 |
70 |
0.045
|
|
|
|
nucleotide metabolic process
|
GO:0009117 |
332 |
0.045
|
|
|
|
neural precursor cell proliferation
|
GO:0061351 |
121 |
0.045
|
|
|
|
b cell proliferation
|
GO:0042100 |
53 |
0.045
|
|
|
|
organophosphate catabolic process
|
GO:0046434 |
232 |
0.044
|
|
|
|
blood vessel morphogenesis
|
GO:0048514 |
285 |
0.044
|
|
|
|
positive regulation of cell motility
|
GO:2000147 |
116 |
0.044
|
|
|
|
tolerance induction
|
GO:0002507 |
14 |
0.044
|
|
|
|
positive regulation of secondary heart field cardioblast proliferation
|
GO:0072513 |
4 |
0.044
|
|
|
|
cellular divalent inorganic cation homeostasis
|
GO:0072503 |
127 |
0.043
|
|
|
|
ossification
|
GO:0001503 |
216 |
0.043
|
|
|
|
negative regulation of nervous system development
|
GO:0051961 |
156 |
0.043
|
|
|
|
rho protein signal transduction
|
GO:0007266 |
32 |
0.043
|
|
|
|
regulation of purine nucleotide metabolic process
|
GO:1900542 |
169 |
0.043
|
|
|
|
organic cyclic compound catabolic process
|
GO:1901361 |
295 |
0.043
|
|
|
|
regulation of ion transport
|
GO:0043269 |
215 |
0.043
|
|
|
|
telencephalon cell migration
|
GO:0022029 |
55 |
0.043
|
|
|
|
negative regulation of protein phosphorylation
|
GO:0001933 |
126 |
0.042
|
|
|
|
regulation of vasculature development
|
GO:1901342 |
88 |
0.042
|
|
|
|
leukocyte chemotaxis
|
GO:0030595 |
69 |
0.042
|
|
|
|
lipid localization
|
GO:0010876 |
126 |
0.042
|
|
|
|
respiratory tube development
|
GO:0030323 |
167 |
0.042
|
|
|
|
regulation of defense response
|
GO:0031347 |
233 |
0.042
|
|
|
|
heart morphogenesis
|
GO:0003007 |
178 |
0.042
|
|
|
|
organonitrogen compound catabolic process
|
GO:1901565 |
264 |
0.042
|
|
|
|
positive regulation of protein phosphorylation
|
GO:0001934 |
242 |
0.042
|
|
|
|
regulation of transferase activity
|
GO:0051338 |
263 |
0.041
|
|
|
|
regulation of organ growth
|
GO:0046620 |
61 |
0.041
|
|
|
|
regulation of hormone levels
|
GO:0010817 |
211 |
0.041
|
|
|
|
purine nucleoside catabolic process
|
GO:0006152 |
205 |
0.041
|
|
|
|
glycoprotein biosynthetic process
|
GO:0009101 |
89 |
0.041
|
|
|
|
purine ribonucleoside catabolic process
|
GO:0046130 |
205 |
0.041
|
|
|
|
regulation of secretion
|
GO:0051046 |
274 |
0.041
|
|
|
|
monocarboxylic acid metabolic process
|
GO:0032787 |
191 |
0.041
|
|
|
|
regulation of antigen receptor mediated signaling pathway
|
GO:0050854 |
29 |
0.041
|
|
|
|
eosinophil degranulation
|
GO:0043308 |
1 |
0.041
|
|
|
|
negative regulation of homeostatic process
|
GO:0032845 |
71 |
0.040
|
|
|
|
guanosine containing compound metabolic process
|
GO:1901068 |
144 |
0.040
|
|
|
|
cell type specific apoptotic process
|
GO:0097285 |
268 |
0.040
|
|
|
|
negative regulation of phosphorylation
|
GO:0042326 |
166 |
0.040
|
|
|
|
gamma delta t cell lineage commitment
|
GO:0002365 |
1 |
0.040
|
|
|
|
cardiac ventricle development
|
GO:0003231 |
83 |
0.040
|
|
|
|
regulation of cell migration
|
GO:0030334 |
219 |
0.040
|
|
|
|
negative regulation of cell proliferation
|
GO:0008285 |
296 |
0.040
|
|
|
|
regulation of blood circulation
|
GO:1903522 |
93 |
0.040
|
|
|
|
tissue remodeling
|
GO:0048771 |
102 |
0.039
|
|
|
|
positive regulation of t helper 1 cell differentiation
|
GO:0045627 |
4 |
0.039
|
|
|
|
regulation of gtp catabolic process
|
GO:0033124 |
113 |
0.039
|
|
|
|
purine ribonucleoside metabolic process
|
GO:0046128 |
241 |
0.039
|
|
|
|
positive regulation of behavior
|
GO:0048520 |
40 |
0.038
|
|
|
|
regulation of interleukin 8 production
|
GO:0032677 |
3 |
0.038
|
|
|
|
microglial cell activation involved in immune response
|
GO:0002282 |
1 |
0.038
|
|
|
|
gland development
|
GO:0048732 |
330 |
0.038
|
|
|
|
regulation of wnt signaling pathway
|
GO:0030111 |
123 |
0.038
|
|
|
|
negative regulation of growth
|
GO:0045926 |
99 |
0.038
|
|
|
|
negative regulation of cellular component organization
|
GO:0051129 |
194 |
0.038
|
|
|
|
regulation of mapk cascade
|
GO:0043408 |
248 |
0.037
|
|
|
|
regulation of purine nucleotide catabolic process
|
GO:0033121 |
122 |
0.037
|
|
|
|
positive regulation of leukocyte proliferation
|
GO:0070665 |
73 |
0.037
|
|
|
|
plasma membrane organization
|
GO:0007009 |
90 |
0.037
|
|
|
|
positive t cell selection
|
GO:0043368 |
23 |
0.037
|
|
|
|
platelet aggregation
|
GO:0070527 |
20 |
0.037
|
|
|
|
cellular calcium ion homeostasis
|
GO:0006874 |
119 |
0.037
|
|
|
|
anatomical structure homeostasis
|
GO:0060249 |
145 |
0.037
|
|
|
|
regulation of toll like receptor 4 signaling pathway
|
GO:0034143 |
4 |
0.037
|
|
|
|
purine containing compound metabolic process
|
GO:0072521 |
311 |
0.036
|
|
|
|
epithelial tube morphogenesis
|
GO:0060562 |
303 |
0.036
|
|
|
|
regulation of phospholipase c activity
|
GO:1900274 |
3 |
0.036
|
|
|
|
positive regulation of hydrolase activity
|
GO:0051345 |
148 |
0.036
|
|
|
|
interleukin 12 secretion
|
GO:0072610 |
3 |
0.036
|
|
|
|
regulation of anatomical structure size
|
GO:0090066 |
178 |
0.036
|
|
|
|
nitrogen compound transport
|
GO:0071705 |
271 |
0.035
|
|
|
|
leukocyte migration
|
GO:0050900 |
124 |
0.035
|
|
|
|
sensory organ morphogenesis
|
GO:0090596 |
242 |
0.035
|
|
|
|
cation homeostasis
|
GO:0055080 |
212 |
0.035
|
|
|
|
negative regulation of defense response
|
GO:0031348 |
77 |
0.035
|
|
|
|
immune complex clearance by monocytes and macrophages
|
GO:0002436 |
2 |
0.035
|
|
|
|
response to growth factor
|
GO:0070848 |
198 |
0.035
|
|
|
|
regulation of vesicle mediated transport
|
GO:0060627 |
139 |
0.034
|
|
|
|
cardiac ventricle morphogenesis
|
GO:0003208 |
50 |
0.034
|
|
|
|
negative regulation of innate immune response
|
GO:0045824 |
17 |
0.034
|
|
|
|
biomineral tissue development
|
GO:0031214 |
64 |
0.034
|
|
|
|
positive regulation of protein modification process
|
GO:0031401 |
299 |
0.034
|
|
|
|
cellular homeostasis
|
GO:0019725 |
240 |
0.034
|
|
|
|
immune complex clearance
|
GO:0002434 |
2 |
0.034
|
|
|
|
hormone secretion
|
GO:0046879 |
128 |
0.034
|
|
|
|
muscle cell differentiation
|
GO:0042692 |
261 |
0.034
|
|
|
|
regulation of kinase activity
|
GO:0043549 |
249 |
0.034
|
|
|
|
positive regulation of interferon gamma production
|
GO:0032729 |
39 |
0.034
|
|
|
|
striated muscle tissue development
|
GO:0014706 |
293 |
0.034
|
|
|
|
positive regulation of cytosolic calcium ion concentration
|
GO:0007204 |
65 |
0.034
|
|
|
|
jnk cascade
|
GO:0007254 |
72 |
0.034
|
|
|
|
regulation of systemic arterial blood pressure
|
GO:0003073 |
61 |
0.034
|
|
|
|
response to molecule of bacterial origin
|
GO:0002237 |
143 |
0.034
|
|
|
|
regulation of immunological synapse formation
|
GO:2000520 |
2 |
0.033
|
|
|
|
positive regulation of adenylate cyclase activity involved in g protein coupled receptor signaling pathway
|
GO:0010579 |
3 |
0.033
|
|
|
|
cellular response to acid chemical
|
GO:0071229 |
68 |
0.033
|
|
|
|
regulation of protein localization
|
GO:0032880 |
231 |
0.033
|
|
|
|
negative regulation of apoptotic signaling pathway
|
GO:2001234 |
104 |
0.033
|
|
|
|
regulation of cellular response to stress
|
GO:0080135 |
159 |
0.033
|
|
|
|
negative regulation of peptidyl tyrosine phosphorylation
|
GO:0050732 |
17 |
0.033
|
|
|
|
pallium development
|
GO:0021543 |
120 |
0.033
|
|
|
|
calcium ion transport into cytosol
|
GO:0060402 |
48 |
0.033
|
|
|
|
tolerance induction to self antigen
|
GO:0002513 |
4 |
0.033
|
|
|
|
ribonucleotide metabolic process
|
GO:0009259 |
291 |
0.033
|
|
|
|
regulation of t cell receptor signaling pathway
|
GO:0050856 |
21 |
0.033
|
|
|
|
negative regulation of cellular protein metabolic process
|
GO:0032269 |
247 |
0.033
|
|
|
|
leukocyte apoptotic process
|
GO:0071887 |
71 |
0.033
|
|
|
|
multicellular organismal homeostasis
|
GO:0048871 |
164 |
0.033
|
|
|
|
nucleotide catabolic process
|
GO:0009166 |
217 |
0.032
|
|
|
|
cdc42 protein signal transduction
|
GO:0032488 |
0 |
0.032
|
|
|
|
regulation of ossification
|
GO:0030278 |
112 |
0.032
|
|
|
|
positive regulation of camp mediated signaling
|
GO:0043950 |
3 |
0.032
|
|
|
|
positive regulation of purine nucleotide catabolic process
|
GO:0033123 |
88 |
0.032
|
|
|
|
negative regulation of lymphocyte apoptotic process
|
GO:0070229 |
24 |
0.031
|
|
|
|
negative regulation of macrophage apoptotic process
|
GO:2000110 |
3 |
0.031
|
|
|
|
positive regulation of protein serine threonine kinase activity
|
GO:0071902 |
106 |
0.031
|
|
|
|
regulation of synaptic growth at neuromuscular junction
|
GO:0008582 |
4 |
0.031
|
|
|
|
ribose phosphate metabolic process
|
GO:0019693 |
291 |
0.031
|
|
|
|
interleukin 8 production
|
GO:0032637 |
4 |
0.031
|
|
|
|
gtp catabolic process
|
GO:0006184 |
143 |
0.031
|
|
|
|
regulation of nucleotide catabolic process
|
GO:0030811 |
122 |
0.031
|
|
|
|
chemotaxis
|
GO:0006935 |
247 |
0.031
|
|
|
|
somatotropin secreting cell differentiation
|
GO:0060126 |
4 |
0.031
|
|
|
|
regulation of organelle organization
|
GO:0033043 |
289 |
0.030
|
|
|
|
carbohydrate derivative catabolic process
|
GO:1901136 |
231 |
0.030
|
|
|
|
ribonucleoside catabolic process
|
GO:0042454 |
206 |
0.030
|
|
|
|
cellular metal ion homeostasis
|
GO:0006875 |
151 |
0.030
|
|
|
|
epithelial cell development
|
GO:0002064 |
159 |
0.030
|
|
|
|
insulin secretion
|
GO:0030073 |
89 |
0.030
|
|
|
|
eosinophil mediated immunity
|
GO:0002447 |
1 |
0.030
|
|
|
|
somatotropin secreting cell development
|
GO:0060133 |
2 |
0.030
|
|
|
|
extracellular structure organization
|
GO:0043062 |
148 |
0.030
|
|
|
|
organic acid biosynthetic process
|
GO:0016053 |
86 |
0.030
|
|
|
|
fc receptor mediated inhibitory signaling pathway
|
GO:0002774 |
1 |
0.030
|
|
|
|
regulation of immune complex clearance by monocytes and macrophages
|
GO:0090264 |
2 |
0.029
|
|
|
|
nucleoside catabolic process
|
GO:0009164 |
206 |
0.029
|
|
|
|
negative regulation of phosphate metabolic process
|
GO:0045936 |
184 |
0.029
|
|
|
|
organic hydroxy compound biosynthetic process
|
GO:1901617 |
77 |
0.029
|
|
|
|
leukocyte mediated cytotoxicity
|
GO:0001909 |
62 |
0.029
|
|
|
|
positive regulation of interleukin 2 biosynthetic process
|
GO:0045086 |
8 |
0.029
|
|
|
|
purine nucleotide metabolic process
|
GO:0006163 |
302 |
0.029
|
|
|
|
pituitary gland development
|
GO:0021983 |
38 |
0.029
|
|
|
|
positive regulation of programmed cell death
|
GO:0043068 |
218 |
0.029
|
|
|
|
negative regulation of camp mediated signaling
|
GO:0043951 |
3 |
0.029
|
|
|
|
regulation of cytoplasmic transport
|
GO:1903649 |
112 |
0.029
|
|
|
|
interleukin 2 production
|
GO:0032623 |
33 |
0.029
|
|
|
|
nucleoside triphosphate metabolic process
|
GO:0009141 |
230 |
0.028
|
|
|
|
regulation of inflammatory response
|
GO:0050727 |
147 |
0.028
|
|
|
|
detection of stimulus
|
GO:0051606 |
84 |
0.028
|
|
|
|
endodermal cell fate specification
|
GO:0001714 |
4 |
0.028
|
|
|
|
osteoclast differentiation
|
GO:0030316 |
62 |
0.028
|
|
|
|
chemokine mediated signaling pathway
|
GO:0070098 |
17 |
0.028
|
|
|
|
positive regulation of alpha beta t cell proliferation
|
GO:0046641 |
12 |
0.028
|
|
|
|
regulation of glial cell differentiation
|
GO:0045685 |
41 |
0.028
|
|
|
|
posttranscriptional regulation of gene expression
|
GO:0010608 |
155 |
0.028
|
|
|
|
regulation of mast cell activation involved in immune response
|
GO:0033006 |
17 |
0.028
|
|
|
|
amide transport
|
GO:0042886 |
138 |
0.028
|
|
|
|
response to organic cyclic compound
|
GO:0014070 |
198 |
0.028
|
|
|
|
purine ribonucleoside triphosphate catabolic process
|
GO:0009207 |
199 |
0.028
|
|
|
|
positive regulation of hematopoietic stem cell migration
|
GO:2000473 |
1 |
0.027
|
|
|
|
cellular response to glucose stimulus
|
GO:0071333 |
45 |
0.027
|
|
|
|
positive regulation of cell projection organization
|
GO:0031346 |
95 |
0.027
|
|
|
|
glycoprotein metabolic process
|
GO:0009100 |
116 |
0.027
|
|
|
|
generation of precursor metabolites and energy
|
GO:0006091 |
103 |
0.027
|
|
|
|
purine ribonucleotide metabolic process
|
GO:0009150 |
290 |
0.027
|
|
|
|
eosinophil activation
|
GO:0043307 |
1 |
0.027
|
|
|
|
endomembrane system organization
|
GO:0010256 |
147 |
0.027
|
|
|
|
regulation of transmembrane receptor protein serine threonine kinase signaling pathway
|
GO:0090092 |
112 |
0.027
|
|
|
|
regulation of nucleotide metabolic process
|
GO:0006140 |
169 |
0.026
|
|
|
|
tissue homeostasis
|
GO:0001894 |
115 |
0.026
|
|
|
|
peptide hormone secretion
|
GO:0030072 |
109 |
0.026
|
|
|
|
negative regulation of molecular function
|
GO:0044092 |
258 |
0.026
|
|
|
|
regulation of neuron death
|
GO:1901214 |
134 |
0.026
|
|
|
|
negative regulation of cell activation
|
GO:0050866 |
111 |
0.026
|
|
|
|
nucleoside triphosphate catabolic process
|
GO:0009143 |
205 |
0.026
|
|
|
|
cerebral cortex development
|
GO:0021987 |
86 |
0.026
|
|
|
|
regulation of peptide secretion
|
GO:0002791 |
77 |
0.026
|
|
|
|
somatic diversification of immune receptors via germline recombination within a single locus
|
GO:0002562 |
51 |
0.026
|
|
|
|
negative regulation of protein modification process
|
GO:0031400 |
163 |
0.026
|
|
|
|
myeloid cell activation involved in immune response
|
GO:0002275 |
34 |
0.026
|
|
|
|
cellular chemical homeostasis
|
GO:0055082 |
215 |
0.026
|
|
|
|
positive regulation of phospholipase activity
|
GO:0010518 |
3 |
0.026
|
|
|
|
gtp metabolic process
|
GO:0046039 |
144 |
0.026
|
|
|
|
regulation of immunoglobulin production
|
GO:0002637 |
42 |
0.025
|
|
|
|
regulation of t cell extravasation
|
GO:2000407 |
3 |
0.025
|
|
|
|
protein localization to organelle
|
GO:0033365 |
185 |
0.025
|
|
|
|
embryonic organ morphogenesis
|
GO:0048562 |
276 |
0.025
|
|
|
|
negative regulation of leukocyte mediated immunity
|
GO:0002704 |
29 |
0.025
|
|
|
|
positive regulation of b cell receptor signaling pathway
|
GO:0050861 |
4 |
0.025
|
|
|
|
regulation of ion homeostasis
|
GO:2000021 |
64 |
0.025
|
|
|
|
blastocyst development
|
GO:0001824 |
80 |
0.025
|
|
|
|
negative regulation of phosphorus metabolic process
|
GO:0010563 |
184 |
0.025
|
|
|
|
mammary gland morphogenesis
|
GO:0060443 |
54 |
0.025
|
|
|
|
membrane organization
|
GO:0061024 |
245 |
0.025
|
|
|
|
cardiac muscle cell proliferation
|
GO:0060038 |
31 |
0.025
|
|
|
|
regulation of intracellular steroid hormone receptor signaling pathway
|
GO:0033143 |
18 |
0.025
|
|
|
|
regulation of interleukin 4 production
|
GO:0032673 |
18 |
0.025
|
|
|
|
bone remodeling
|
GO:0046849 |
53 |
0.025
|
|
|
|
positive regulation of immunological synapse formation
|
GO:2000522 |
1 |
0.024
|
|
|
|
interleukin 1 production
|
GO:0032612 |
31 |
0.024
|
|
|
|
spinal cord development
|
GO:0021510 |
81 |
0.024
|
|
|
|
digestive tract morphogenesis
|
GO:0048546 |
147 |
0.024
|
|
|
|
positive regulation of gtp catabolic process
|
GO:0033126 |
85 |
0.024
|
|
|
|
nucleoside phosphate catabolic process
|
GO:1901292 |
222 |
0.024
|
|
|
|
stress activated protein kinase signaling cascade
|
GO:0031098 |
81 |
0.024
|
|
|
|
microtubule based process
|
GO:0007017 |
236 |
0.024
|
|
|
|
fatty acid metabolic process
|
GO:0006631 |
121 |
0.024
|
|
|
|
positive regulation of phospholipase c activity
|
GO:0010863 |
2 |
0.024
|
|
|
|
regulation of cytokine biosynthetic process
|
GO:0042035 |
59 |
0.024
|
|
|
|
actin filament organization
|
GO:0007015 |
113 |
0.024
|
|
|
|
response to organonitrogen compound
|
GO:0010243 |
246 |
0.024
|
|
|
|
regulation of blood vessel size
|
GO:0050880 |
56 |
0.024
|
|
|
|
regulation of b cell mediated immunity
|
GO:0002712 |
37 |
0.024
|
|
|
|
hair follicle development
|
GO:0001942 |
85 |
0.024
|
|
|
|
positive regulation of monocyte extravasation
|
GO:2000439 |
1 |
0.024
|
|
|
|
negative regulation of smoothened signaling pathway
|
GO:0045879 |
25 |
0.023
|
|
|
|
mature dendritic cell differentiation
|
GO:0097029 |
3 |
0.023
|
|
|
|
regulation of intracellular transport
|
GO:0032386 |
159 |
0.023
|
|
|
|
mesodermal cell migration
|
GO:0008078 |
4 |
0.023
|
|
|
|
negative regulation of response to wounding
|
GO:1903035 |
77 |
0.023
|
|
|
|
nucleoside metabolic process
|
GO:0009116 |
246 |
0.023
|
|
|
|
positive regulation of angiogenesis
|
GO:0045766 |
46 |
0.023
|
|
|
|
t cell activation involved in immune response
|
GO:0002286 |
43 |
0.023
|
|
|
|
positive regulation of secretion by cell
|
GO:1903532 |
114 |
0.023
|
|
|
|
regulation of endopeptidase activity
|
GO:0052548 |
89 |
0.023
|
|
|
|
cardiac muscle tissue growth
|
GO:0055017 |
37 |
0.023
|
|
|
|
carbohydrate transport
|
GO:0008643 |
62 |
0.023
|
|
|
|
regulation of system process
|
GO:0044057 |
200 |
0.023
|
|
|
|
positive regulation of nucleotide metabolic process
|
GO:0045981 |
114 |
0.023
|
|
|
|
negative regulation of epithelial cell proliferation
|
GO:0050680 |
64 |
0.023
|
|
|
|
alcohol metabolic process
|
GO:0006066 |
116 |
0.023
|
|
|
|
purine nucleoside triphosphate metabolic process
|
GO:0009144 |
226 |
0.023
|
|
|
|
pulmonary valve formation
|
GO:0003193 |
1 |
0.023
|
|
|
|
regulation of ras protein signal transduction
|
GO:0046578 |
114 |
0.023
|
|
|
|
ribonucleoside metabolic process
|
GO:0009119 |
245 |
0.023
|
|
|
|
endocrine process
|
GO:0050886 |
39 |
0.023
|
|
|
|
nuclear transport
|
GO:0051169 |
139 |
0.023
|
|
|
|
stem cell maintenance
|
GO:0019827 |
130 |
0.023
|
|
|
|
developmental growth involved in morphogenesis
|
GO:0060560 |
138 |
0.023
|
|
|
|
positive regulation of kinase activity
|
GO:0033674 |
155 |
0.022
|
|
|
|
cellular ion homeostasis
|
GO:0006873 |
165 |
0.022
|
|
|
|
regulation of peptide transport
|
GO:0090087 |
91 |
0.022
|
|
|
|
interleukin 10 secretion
|
GO:0072608 |
4 |
0.022
|
|
|
|
b cell mediated immunity
|
GO:0019724 |
71 |
0.022
|
|
|
|
positive regulation of t cell receptor signaling pathway
|
GO:0050862 |
4 |
0.022
|
|
|
|
regulation of muscle tissue development
|
GO:1901861 |
97 |
0.022
|
|
|
|
ameboidal type cell migration
|
GO:0001667 |
128 |
0.022
|
|
|
|
mitotic cell cycle
|
GO:0000278 |
195 |
0.022
|
|
|
|
positive regulation of cytokine secretion
|
GO:0050715 |
41 |
0.022
|
|
|
|
antigen processing and presentation
|
GO:0019882 |
47 |
0.022
|
|
|
|
cellular response to hexose stimulus
|
GO:0071331 |
47 |
0.022
|
|
|
|
negative regulation of intracellular signal transduction
|
GO:1902532 |
167 |
0.021
|
|
|
|
dna metabolic process
|
GO:0006259 |
303 |
0.021
|
|
|
|
purine nucleoside metabolic process
|
GO:0042278 |
241 |
0.021
|
|
|
|
placenta development
|
GO:0001890 |
140 |
0.021
|
|
|
|
extrinsic apoptotic signaling pathway in absence of ligand
|
GO:0097192 |
55 |
0.021
|
|
|
|
negative regulation of transferase activity
|
GO:0051348 |
85 |
0.021
|
|
|
|
protein localization to membrane
|
GO:0072657 |
108 |
0.021
|
|
|
|
ribonucleoside triphosphate catabolic process
|
GO:0009203 |
199 |
0.021
|
|
|
|
cellular response to transforming growth factor beta stimulus
|
GO:0071560 |
88 |
0.021
|
|
|
|
glycosyl compound catabolic process
|
GO:1901658 |
206 |
0.021
|
|
|
|
lymphocyte costimulation
|
GO:0031294 |
15 |
0.021
|
|
|
|
transmembrane receptor protein serine threonine kinase signaling pathway
|
GO:0007178 |
194 |
0.021
|
|
|
|
peptide secretion
|
GO:0002790 |
114 |
0.021
|
|
|
|
regulation of smoothened signaling pathway
|
GO:0008589 |
58 |
0.021
|
|
|
|
small molecule biosynthetic process
|
GO:0044283 |
132 |
0.021
|
|
|
|
oxidation reduction process
|
GO:0055114 |
342 |
0.021
|
|
|
|
striated muscle cell development
|
GO:0055002 |
125 |
0.021
|
|
|
|
regulation of blood coagulation
|
GO:0030193 |
28 |
0.021
|
|
|
|
tumor necrosis factor production
|
GO:0032640 |
50 |
0.021
|
|
|
|
positive regulation of endocytosis
|
GO:0045807 |
42 |
0.021
|
|
|
|
reactive nitrogen species metabolic process
|
GO:2001057 |
0 |
0.020
|
|
|
|
regulation of homeostatic process
|
GO:0032844 |
182 |
0.020
|
|
|
|
cellular nitrogen compound catabolic process
|
GO:0044270 |
280 |
0.020
|
|
|
|
astrocyte differentiation
|
GO:0048708 |
43 |
0.020
|
|
|
|
ear development
|
GO:0043583 |
200 |
0.020
|
|
|
|
regulation of protein complex assembly
|
GO:0043254 |
83 |
0.020
|
|
|
|
negative regulation of vasculature development
|
GO:1901343 |
26 |
0.020
|
|
|
|
heart growth
|
GO:0060419 |
45 |
0.020
|
|
|
|
neuron projection guidance
|
GO:0097485 |
141 |
0.020
|
|
|
|
negative regulation of mast cell proliferation
|
GO:0070667 |
1 |
0.020
|
|
|
|
glucose homeostasis
|
GO:0042593 |
128 |
0.020
|
|
|
|
positive regulation of ion transport
|
GO:0043270 |
65 |
0.020
|
|
